• Eli Lilly EPS for the quarter ending September 30, 2024 was $1.07, a 1883.33% decline year-over-year.
• Eli Lilly 2023 annual EPS was $5.8, a 15.94% decline from 2022.
• Eli Lilly 2022 annual EPS was $6.9, a 12.75% increase from 2021.
• Eli Lilly 2021 annual EPS was $6.12, a 9.87% decline from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.